Article Information
History
- February 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Suman Das1,*,
- Janmejay Singh2,*,
- Heena Shaman2,*,
- Balwant Singh2,
- Anbalagan Anantharaj2,
- Patil Sharanabasava2,
- Rajesh Pandey3,
- Rakesh Lodha4,
- Anil Kumar Pandey1 and
- Guruprasad R. Medigeshi2,#
- 1Employees State Insurance Corporation Medical College and Hospital, Faridabad, Haryana, INDIA
- 2Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
- 3INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology, Delhi, INDIA
- 4All India Institute of Medical Sciences, New Delhi, INDIA
- ↵#Corresponding author:
Guruprasad R. Medigeshi, PhD, Translational Health Science and Technology Institute, P.O. Box # 4, Faridabad-Gurgaon Highway, Faridabad 121001. INDIA. Tel: +91-0129-2876311. Email: gmedigeshi{at}thsti.res.in
↵* These authors contributed equally
Posted February 08, 2022.
Antibody response after a single dose of BBV152 vaccine negatively correlates with pre-existing antibodies and induces a significant but low levels of neutralizing antibodies to Omicron variant
